As of 13 July 2021, BNP Paribas received the necessary approvals and acquired 100% of Exane, raising its stake from the 50% previously held during a successful 17-year partnership. This transaction will further strengthen and widen the range of cash equities (execution and research) and derivatives services BNP Paribas can offer to institutional investors and corporates globally.
BNP Paribas Global Markets, one of the three businesses of BNP Paribas' Corporate and Institutional Bank, provides cross-asset investment, hedging, financing, and economics and strategy market intelligence to corporate and institutional clients, and private and retail banking networks. Click here for more information about BNP Paribas Global Markets.
Note: BNP Paribas and Exane are working closely towards a seamless and smooth transition, which includes the sharing of certain client information, in line with each entity's regulatory requirements.
BNP Paribas Exane is a leading European equities business. We offer a high quality execution platform with full electronic trading capability. Our Research product is renowned for its depth and quality and is reinforced by experienced, top-ranked Sales & Specialist Sales teams as well as a dedicated corporate access service.
We have invested consistently over recent cycles to build a top Industry Research franchise which was ranked Number 1 in Europe for six years in a row (2022, 2021, 2020 Institutional Investor surveys; and 2019, 2018, 2017 Extel surveys). We ranked No.1 in 14 Research categories and ranked Top 3 in 25 categories.
We believe this success is due to our focus on innovative, high quality Research and data. We will continue to invest to strengthen our Research product and provide a better service clients.
STRONG DISTRIBUTION & ACCESS
We believe that high quality content deserves proper distribution. That's why we have a well-resourced and highly-experienced Sales team with a local presence in most major markets and a Specialist Sales desk with full coverage of the equity sectors. We were also ranked 1st for Europe Equity Sales in the 2022, 2021, 2020 Institutional Investor surveys and in the three consecutive Extel surveys (2019, 2018, 2017).
Connecting investors with corporates is also a critical role for us. In 2021, we hosted around 30 conferences and field trips, 130 expert access events, 500 roadshows and organised over 5,500 investor meetings thanks to our Corporate Access service offering.
We believe that execution quality matters more than ever. We offer a full suite of trading products across high touch, electronic trading, ETF and program trading. Our experienced team and cutting-edge technology make us key partners for major investors on European equities.
We have built a strong Electronic Trading platform, where we continue to add new counterparts and where volumes are rising significantly. BNP Paribas Exane was recognised as the overall outperformer with long-only investors in The Trade's Algorithmic Trading Survey 2022 for the third year in a row, achieving an average score of 6.42. In the survey, BNP Paribas Exane is ranked #1 in 13 of the 15 available categories, and #2 in the remaining two categories. Top rated services include order routing, customisation, algo monitoring and execution consistency, for which the bank received its strongest ever result.